Mardakheh Faraz K, Self Annette, Marshall Christopher J
Institute of Cancer Research, Division of Cancer Biology, 237 Fulham Road, London SW3 6JB, UK
Institute of Cancer Research, Division of Cancer Biology, 237 Fulham Road, London SW3 6JB, UK.
J Cell Sci. 2016 Dec 15;129(24):4466-4479. doi: 10.1242/jcs.198614. Epub 2016 Nov 2.
Directional cell migration involves reorientation of the secretory machinery. However, the molecular mechanisms that control this reorientation are not well characterised. Here, we identify a new Rho effector protein, named FAM65A, which binds to active RHOA, RHOB and RHOC. FAM65A links RHO proteins to Golgi-localising cerebral cavernous malformation-3 protein (CCM3; also known as PDCD10) and its interacting proteins mammalian STE20-like protein kinases 3 and 4 (MST3 and MST4; also known as STK24 and STK26, respectively). Binding of active RHO proteins to FAM65A does not affect the kinase activity of MSTs but results in their relocation from the Golgi in a CCM3-dependent manner. This relocation is crucial for reorientation of the Golgi towards the leading edge and subsequent directional cell migration. Our results reveal a previously unidentified pathway downstream of RHO that regulates the polarity of migrating cells through Golgi reorientation in a FAM65A-, CCM3- and MST3- and MST4-dependent manner.
定向细胞迁移涉及分泌机制的重新定向。然而,控制这种重新定向的分子机制尚未得到充分表征。在这里,我们鉴定出一种新的Rho效应蛋白,名为FAM65A,它与活性RHOA、RHOB和RHOC结合。FAM65A将Rho蛋白与定位于高尔基体的脑海绵状血管畸形3蛋白(CCM3;也称为PDCD10)及其相互作用蛋白哺乳动物STE20样蛋白激酶3和4(MST3和MST4;也分别称为STK24和STK26)联系起来。活性Rho蛋白与FAM65A的结合不会影响MSTs的激酶活性,但会导致它们以CCM3依赖的方式从高尔基体重新定位。这种重新定位对于高尔基体向前缘的重新定向以及随后的定向细胞迁移至关重要。我们的结果揭示了Rho下游一条以前未被识别的途径,该途径通过以FAM65A、CCM3、MST3和MST4依赖的方式进行高尔基体重新定向来调节迁移细胞的极性。